Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
838 studies found for:    "Crohns disease"
Show Display Options
Rank Status Study
1 Completed STA-5326 in Crohn's Disease Patients
Condition: Crohn's Disease
Intervention: Drug: STA-5326
2 Enrolling by invitation Clinical Course of Korean Crohn's Disease Cohort
Condition: Crohn's Disease
Intervention: Other: Observation study
3 Completed EPANOVA in Crohn's Disease, Study 1
Condition: Crohn's Disease
Intervention: Drug: Epanova
4 Unknown  Evaluation of PET CT in the Management of Patients With Crohn's Disease.
Condition: Crohn's Disease
Intervention: Radiation: FDG PET CT
5 Unknown  Pravastatin Therapy in Patients With Active Crohn's Disease: A Pilot Study
Condition: Crohn's Disease
Intervention: Drug: Pravastatin
6 Active, not recruiting Special Investigation on Long-term Treatment in Patients With Crohn's Disease
Condition: Crohn's Disease
Intervention:
7 Completed Evaluation of Small Bowel Colon Capsule for Bowel Visualization in Crohn's Disease Patients
Condition: Crohn Disease
Intervention:
8 Completed
Has Results
Special Investigation in Patients With Crohn's Disease (All Patients Investigation)
Condition: Crohn's Disease
Intervention:
9 Terminated Safety and Efficacy Study in the Treatment of Pediatric Crohn's Disease
Condition: Crohn Disease
Intervention: Drug: Sargramostim (Leukine)
10 Terminated Imuran Dosing in Crohn's Disease Study
Condition: Crohn's Disease
Intervention: Drug: IMURAN (azathioprine)
11 Recruiting A Phase 1/2 Study of Repeated Intravenous E6011 Administration in Japanese Subjects With Crohn's Disease
Condition: Crohn's Disease
Interventions: Drug: E6011 2 mg/kg;   Drug: E6011 5 mg/kg;   Drug: E6011 10 mg/kg;   Drug: E6011 15 mg/kg
12 Completed
Has Results
Study for the Treatment of Crohn's Disease With Adacolumn
Condition: Crohn's Disease
Interventions: Device: Adacolumn;   Device: Sham
13 Active, not recruiting Extension Study of MT-1303 in Subjects With Crohn's Disease
Condition: Crohn's Disease
Intervention: Drug: MT-1303
14 Active, not recruiting Urinary Prostaglandin E Metabolite (PGE-M), A Metabolite of Prostaglandin E2 (PGE2): A Novel Biomarker of Crohn's Disease Activity
Condition: Crohn's Disease
Interventions: Procedure: Fecal calprotectin;   Procedure: Urinary PGE-M Level
15 Recruiting Assessing the Tolerability of Oligosaccharide Supplementation in Patients With Crohn's Disease
Condition: Crohn's Disease
Interventions: Dietary Supplement: Placebo;   Dietary Supplement: Moderate Oligosaccharide Group;   Dietary Supplement: High Oligosaccharide Group
16 Completed
Has Results
Safety and Maintenance Study of Entocort for Children With Crohn's Disease
Condition: Crohn's Disease
Intervention: Drug: Entocort
17 Completed An Efficacy and Safety Study of Anti-TNF Monoclonal Antibody in Patients With Crohn's Disease
Condition: Crohn Disease
Interventions: Drug: Infliximab 5 mg/kg;   Drug: Infliximab 10 mg/kg;   Drug: Infliximab 20 mg/kg;   Drug: Placebo
18 Terminated Study of Nitazoxanide Tablets in the Treatment of Mild to Moderate Active Crohn's Disease
Condition: Crohn's Disease
Interventions: Drug: Nitazoxanide;   Other: Placebo
19 Completed Pharmacokinetics (PK), Pharmacodynamics (PD) and Safety Study of MT-1303 in Subjects With Crohn's Disease
Condition: Crohn's Disease
Intervention: Drug: MT-1303
20 Completed A Safety and Efficacy Study of Infliximab (Remicade) in Patients With Moderate to Severe Active Crohn's Disease
Condition: Crohn Disease
Intervention: Drug: infliximab or placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.